The Role of CA ‐125 in the Management of Ovarian Cancer: A Systematic Review
Cancer Reports · 2025
DOI: 10.1002/cnr2.70142 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Reports, 2025. Verfasst von Zohre Momenimovahed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Health Department, Qom University of Medical Sciences, Qom, Iran. Hauptthemen laut MEDLINE: Ovarian Neoplasms, CA-125 Antigen, Biomarkers, Tumor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ovarian cancer is frequently occurring and fatal for women. CA‐125 is important in the screening, diagnosis, and treatment of ovarian cancer. This review study was conducted to explore the influence of CA‐125 in addressing ovarian cancer.
Methods
To investigate the role of CA‐125 in ovarian cancer, we conducted a comprehensive search for high‐quality articles in the Medline, Web of Science Core Collection and Scopus databases using the keywords “ovarian cancer,” “ovarian carcinoma,” “ovarian neoplasms,” and “CA‐125” from the 2000 to 2024. We included full‐text, peer‐reviewed articles in English with relevant keywords published since 2000. We excluded case reports, commentaries, letters to the editor, books, case series, systematic reviews, animal studies, and articles that were not accessible in full text.
Results
After screening the 7947 records, 88 studies were included in this review. In the literature review, it was found that researchers utilized CA‐125 for diagnosing ovarian cancer, its predicting, evaluating treatment response, assessing ovarian cancer survival, and early detection of recurrence. In some cases, researchers employed additional tumor markers alongside CA‐125 to enhance the test's sensitivity.
Conclusion
CA‐125 has become a pivotal marker for ovarian cancer. Its role in the diagnosis, treatment, and ongoing assessment of ovarian cancer cannot be overstated. Continuous monitoring of CA‐125 levels can provide comprehensive insights, and categorizing patients as low‐risk or high‐risk based on CA‐125 levels could lead to better outcomes. Integrating CA‐125 with other biomarkers may enhance the accuracy of the test and elevate its relevance in patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Health Department, Qom University of Medical Sciences, Qom, Iran.
- Shiraz University of Medical Sciences, Shiraz, Iran.
- Midwifery Department, Ministry of Health and Medical Education, Tehran, Iran.
- Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.
ORCID-Profile: Hamid Salehiniya
Zitieren
APA
Momenimovahed, Z., Mazidimoradi, A., Allahqoli, L., & Salehiniya, H. (2025). The Role of CA ‐125 in the Management of Ovarian Cancer: A Systematic Review. Cancer Reports. https://doi.org/10.1002/cnr2.70142
Vancouver
Momenimovahed Z, Mazidimoradi A, Allahqoli L, Salehiniya H. The Role of CA ‐125 in the Management of Ovarian Cancer: A Systematic Review. Cancer Reports. 2025. doi:10.1002/cnr2.70142
BibTeX
@article{Momenimovahed2025,
author = {Momenimovahed, Zohre and Mazidimoradi, Afrooz and Allahqoli, Leila and Salehiniya, Hamid},
title = {The Role of CA ‐125 in the Management of Ovarian Cancer: A Systematic Review},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70142}
}
EUVIMED